Showing results (451-460 of 471) with videos related to

Sort By:
Pageof 48
Archives of Otolaryngology--Head & Neck Surgery|June 24, 2004
Disability in patients with head and neck cancerJoseph C Taylor, Jeffrey E Terrell, David L Ronis, et al.
Vox Sanguinis|December 15, 2017
Postauthorization safety study of Clottafact® , a triply secured fibrinogen concentrate in acquired fibrinogen deficiency: a prospective observational studyC Négrier, A-S Ducloy-Bouthors, V Piriou, et al.
Cardiovascular Digital Health Journal|March 10, 2022
Atrial fibrillation future clinic. Novel platform to integrate smart device electrocardiogram into clinical practiceCameron T Lambert, Divyang Patel, Joseph M Bumgarner, et al.
JCI Insight|February 1, 2022
The molecular chaperone GRP170 protects against ER stress and acute kidney injury in miceAidan W Porter, Diep N Nguyen, Dennis R Clayton, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 4, 2025
Effects of maternal edible THC consumption on offspring lung growth and function in a rhesus macaque modelLyndsey E Shorey-Kendrick, B Adam Crosland, Matthias C Schabel, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 3, 2023
Chronic alcohol use primes bronchial cells for altered inflammatory response and barrier dysfunction during SARS-CoV-2 infectionKristen F Easley, R Clayton Edenfield, Megan E J Lott, et al.
Elife|October 4, 2021
Parallel functional testing identifies enhancers active in early postnatal mouse brainJason T Lambert, Linda Su-Feher, Karol Cichewicz, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 17, 2017
Natural history and clinical characteristics of inhibitors in previously treated haemophilia A patients: a case seriesA Iorio, A M Barbara, M Makris, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2015
Design and synthesis of a novel series of [1-(4-hydroxy-benzyl)-1H-indol-5-yloxy]-acetic acid compounds as potent, selective, thyroid hormone receptor β agonistsTimothy P Burkholder, Brian E Cunningham, Joshua R Clayton, et al.
Investigational New Drugs|March 2, 2011
Discovery of LY2457546: a multi-targeted anti-angiogenic kinase inhibitor with a novel spectrum of activity and exquisite potency in the acute myelogenous leukemia-Flt-3-internal tandem duplication mutant human tumor xenograft modelTimothy P Burkholder, Joshua R Clayton, Mark E Rempala, et al.
Pageof 48